Maria A. Gerochristou

Athens, ESYE31, Greece

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications

Response to Zou et al, "Comment on "Clinical features, treatment outcomes, and immunologic profile of immune checkpoint inhibitor-associated bullous pemphigoid: A retrospective multicenter cohort study"".

Response to Zou et al, "Comment on "Clinical features, treatment outcomes, and immunologic profile of immune checkpoint inhibitor-associated bullous pemphigoid: A retrospective multicenter cohort study"".

Journal: Journal of the American Academy of Dermatology
Published: April 29, 2026

Photoprotective practices in patients with mycosis fungoides: a questionnaire-based survey study.

Photoprotective practices in patients with mycosis fungoides: a questionnaire-based survey study.

Journal: Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
Published: January 11, 2026

Clinical features, treatment outcomes, and immunologic profile of immune checkpoint inhibitor-associated bullous pemphigoid: A retrospective multicenter cohort study.

Clinical features, treatment outcomes, and immunologic profile of immune checkpoint inhibitor-associated bullous pemphigoid: A retrospective multicenter cohort study.

Journal: Journal of the American Academy of Dermatology
Published: December 09, 2025

Sjögren disease and cutaneous sarcoidosis: an association to consider or a co-existence?

Sjögren disease and cutaneous sarcoidosis: an association to consider or a co-existence?

Journal: Clinical rheumatology
Published: August 14, 2025

Treatment Resistant Acneiform Eruption in a Young Female: A Diagnostic Pitfall.

Treatment Resistant Acneiform Eruption in a Young Female: A Diagnostic Pitfall.

Journal: Dermatopathology (Basel, Switzerland)
Published: July 24, 2025

Dual Immune-Related Toxicities: Secukinumab-Induced Bullous Pemphigoid Following ICI-Associated Psoriasis in a Cancer Patient.

Dual Immune-Related Toxicities: Secukinumab-Induced Bullous Pemphigoid Following ICI-Associated Psoriasis in a Cancer Patient.

Journal: International journal of dermatology
Published: February 25, 2025

Epidemiology and management of pemphigus in Greece: A 5-year, multicentre study.

Epidemiology and management of pemphigus in Greece: A 5-year, multicentre study.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: February 23, 2025

Drug associated bullous pemphigoid: what's new?

Drug associated bullous pemphigoid: what's new?

Journal: Italian journal of dermatology and venereology
Published: February 03, 2025

Incidence trends of primary cutaneous B- and T-cell lymphoma before and after the COVID-19 pandemic.

Incidence trends of primary cutaneous B- and T-cell lymphoma before and after the COVID-19 pandemic.

Journal: Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
Published: November 04, 2024

Clinical features, treatment options and outcomes in primary cutaneous B-cell lymphomas: a real-world, multicenter, retrospective study.

Clinical features, treatment options and outcomes in primary cutaneous B-cell lymphomas: a real-world, multicenter, retrospective study.

Journal: International journal of dermatology
Published: August 26, 2024

Treatment of pemphigus foliaceus with upadacitinib.

Treatment of pemphigus foliaceus with upadacitinib.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: June 07, 2024

Beneath the surface: Novel insights into Amivantamab-induced acneiform rash.

Beneath the surface: Novel insights into Amivantamab-induced acneiform rash.

Journal: European journal of cancer (Oxford, England : 1990)
Published: May 02, 2024
Showing 1-12 of 33

Last Updated: 09/26/2026